A detailed history of Life Pro Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Life Pro Asset Management holds 1,394 shares of ABBV stock, worth $252,509. This represents 0.21% of its overall portfolio holdings.

Number of Shares
1,394
Previous 1,338 4.19%
Holding current value
$252,509
Previous $229,000 20.09%
% of portfolio
0.21%
Previous 0.18%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$163.84 - $199.33 $9,175 - $11,162
56 Added 4.19%
1,394 $275,000
Q2 2024

Jul 10, 2024

SELL
$154.79 - $180.76 $3,560 - $4,157
-23 Reduced 1.69%
1,338 $229,000
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $217,515 - $247,838
1,361 New
1,361 $247,000
Q2 2022

Jul 15, 2022

BUY
$137.62 - $174.96 $226,522 - $287,984
1,646 Added 119.19%
3,027 $464,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $81,959 - $101,688
-621 Reduced 31.02%
1,381 $224,000
Q4 2021

Jan 31, 2022

BUY
$107.43 - $135.93 $215,074 - $272,131
2,002 New
2,002 $271,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $320B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Life Pro Asset Management Portfolio

Follow Life Pro Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Life Pro Asset Management with notifications on news.